​

Bright Minds Biosciences (DRUG) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

DRUG Stock Forecast

Bright Minds Biosciences (DRUG) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $159.50, with a high of $220.00 and a low of $126.00. This represents a 135.95% increase from the last price of $67.60.

- $50 $100 $150 $200 $250 High: $220 Avg: $159.5 Low: $126 Last Closed Price: $67.6

DRUG Stock Rating

Bright Minds Biosciences stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

DRUG Price Target Upside V Benchmarks

TypeNameUpside
StockBright Minds Biosciences135.95%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%
IdeaPsychedelic Stocks List63.73%

Price Target Trends

1M3M12M
# Anlaysts-25
Avg Price Target-$182.50$156.00
Last Closing Price$67.60$67.60$67.60
Upside/Downside-169.97%130.77%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2616---7
Jun, 2616---7
May, 2616---7
Apr, 2615---6
Mar, 2616---7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 02, 2026Pat TrucchioH.C. Wainwright$145.00$81.0278.97%114.50%
May 20, 2026Piper Sandler$220.00$74.54195.14%225.44%
Feb 13, 2026Robert W. Baird$126.00$78.7160.08%86.39%
Jan 07, 2026Robert W. Baird$142.00$81.7073.81%110.06%
Jan 07, 2026BTIG$147.00$93.2157.71%117.46%
May 07, 2025Rudy LiChardan Capital$80.00$29.02175.67%18.34%
Jan 10, 2025Patrick TrucchioH.C. Wainwright$85.00$38.89118.57%25.74%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 02, 2026H.C. WainwrightBuyBuyhold
May 20, 2026Piper SandlerOverweightOverweighthold
Jan 07, 2026BTIGBuyBuyhold
Dec 31, 2025H.C. WainwrightBuyBuyhold
Dec 01, 2025Cantor FitzgeraldOverweightOverweighthold
Sep 08, 2025BTIGBuyinitialise
May 13, 2025Cowen & Co.Buyinitialise
Jan 10, 2025Cantor FitzgeraldOverweightinitialise
Jan 10, 2025H.C. WainwrightBuyinitialise

Financial Forecast

EPS Forecast

$-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 $1 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported------
Avg Forecast$-0.81$-1.75$-2.78$-3.23$-5.31$-4.61
High Forecast$-0.81$-0.76$-0.87$0.15$-5.31$-4.61
Low Forecast$-0.81$-3.61$-4.69$-6.61$-5.31$-4.61
Surprise %------

Revenue Forecast

Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported------
Avg Forecast-----$53.09M
High Forecast-----$53.09M
Low Forecast-----$53.09M
Surprise %------

Net Income Forecast

$-25M $-19M $-13M $-7M $-1M $5M Sep 24 Sep 25 Sep 26 Sep 27 Sep 28 Sep 29
Sep 24Sep 25Sep 26Sep 27Sep 28Sep 29
Reported------
Avg Forecast$-3.02M$-8.12M$-10.35M$-12.01M$-19.74M$-17.14M
High Forecast$-3.02M$-2.81M$-3.25M$572.10K$-19.74M$-17.14M
Low Forecast$-3.02M$-13.44M$-17.45M$-24.60M$-19.74M$-17.14M
Surprise %------

DRUG Forecast FAQ

Is Bright Minds Biosciences stock a buy?

Bright Minds Biosciences stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Bright Minds Biosciences is a favorable investment for most analysts.

What is Bright Minds Biosciences's price target?

Bright Minds Biosciences's price target, set by 4 Wall Street analysts, averages $159.5 over the next 12 months. The price target range spans from $126 at the low end to $220 at the high end, suggesting a potential 135.95% change from the previous closing price of $67.6.

How does Bright Minds Biosciences stock forecast compare to its benchmarks?

Bright Minds Biosciences's stock forecast shows a 135.95% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%), leading the psychedelic stocks list (63.73%) investment idea.

What is the breakdown of analyst ratings for Bright Minds Biosciences over the past three months?

  • July 2026: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Bright Minds Biosciences’s EPS forecast?

Bright Minds Biosciences's average annual EPS forecast for its fiscal year ending in September 2024 is $-0.81, marking a 0% decrease from the reported - in 2023. Estimates for the following years are $-1.75 in 2025, $-2.78 in 2026, $-3.23 in 2027, $-5.31 in 2028, and $-4.61 in 2029.

What is Bright Minds Biosciences’s revenue forecast?

Bright Minds Biosciences's average annual revenue forecast for its fiscal year ending in September 2024 is $0, reflecting a 0% decrease from the reported - in 2023. The forecast for 2025 is $0, followed by $0 for 2026, $0 for 2027, $0 for 2028, and $53.09M for 2029.

What is Bright Minds Biosciences’s net income forecast?

Bright Minds Biosciences's net income forecast for the fiscal year ending in September 2024 stands at $-3.024M, representing a 0% decrease from the reported - in 2023. Projections indicate $-8.124M in 2025, $-10.351M in 2026, $-12.014M in 2027, $-19.74M in 2028, and $-17.136M in 2029.